DPM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sumitomo Pharma Co Ltd

Watchlist Manager

Watchlist

Price: 8.17 EUR 2.42% Market Closed

Market Cap: €12.4B

S	Sumitomo Pharma Co Ltd DUS:DPM	JP
M	Mckesson Corp XBER:MCK	US
	Melia Hotels International SA MAD:MEL	ES
E	Eli Lilly and Co XMUN:LLY	US
H	Hyundai Motor Co DUS:HYU	KR
R	RWE AG F:RWE	DE
K	Kalbe Farma Tbk PT F:LCLA	ID
M	McDonald's Corp BMV:MCD	US
E	Empresa Distribuidora y Comercializadora Norte SA BCBA:EDN	AR
K	Kohls Corp F:KHP	US
S	Southern Co XHAM:SOT	US

Profitability Summary

Sumitomo Pharma Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

59%

Strong 3Y Average Gross Margin

61%

Declining Gross Margin

68% > 59%

Healthy Operating Margin

28%

Negative 3Y Average Operating Margin

-30%

Operating Margin is Increasing

-10% > 28%

Healthy Net Margin

24%

Negative 3Y Average Net Margin

-32%

Net Margin is Increasing

-13% > 24%

Healthy Free Cash Flow Margin

10%

Negative 3Y Average Free Cash Flow Margin

-28%

Free Cash Flow Margin is Increasing

0% > 10%

Exceptional ROE

48%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-9%

ROIC is Increasing

-11% > 20%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.